This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience.
View our privacy policy to learn more.
OK
Search Options
Join SITC
Renew
Make a Gift
Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Subscribe
Skip main navigation (Press Enter).
Toggle navigation
Educational & Scientific Programs
ConnectED
Advances in Cancer Immunotherapy™
Collaborative Education Programs
Spring Scientific
2024 Spring Scientific
Past and Future Spring Scientific Programs
Workshops
Tumor Immune Microenvironment: A Holistic Approach
Surfaceome Virtual Workshop
Bispecific T cell Engagers Virtual Workshop
Cytokines in Cancer Immunotherapy Virtual Workshop
Call for Proposals
Annual Meeting & Pre-Conference Programs
38th Annual Meeting & Pre-Conference Programs
Past and Future Annual Meetings & Pre-Conference Programs
Cancer Immunotherapy Winter School
Patient and Survivor Education and Resources
Webinars and Online Education
ACI Online Interactive Courses
Advances in Cancer Immunotherapy (ACI) Webinars
Immune Exclusion Virtual Summit
Immunoprevention Virtual Summit
Meet-the-Expert Webinars
SITC Clinical Practice Guidelines Online Education
SITC-NCI Computational IO Series
Targets for Cancer IO A Deep Dive Series
Calendar of Events
Professional Development & Training
Certificate in Cancer Immunotherapy
Meet-the-Expert Program
Meet-the-Expert Webinars
NCI Fellowship Recipients
SITC Sparkathon
Sparkathon 2024
Sparkathon 2023
Support Sparkathon
Other Resources
Calendar of Events
Path to SITC Leadership
Clinical Trials Training and Resources
2024 SITC Clinical Immuno-Oncology Network (SCION) Workshop
Maximizing the Value of Phase III Trials in Immuno-Oncology
Professional Interest Communities
Fellowships
Women in Cancer Immunotherapy Network (WIN)
Women in Cancer Immunotherapy Network 2023
Women in SITC Community
Early Career Scientist (ECS) Committee
Publications & Guidelines
Journal for ImmunoTherapy of Cancer
About JITC
Become a Reviewer
For Authors
From the Editors
JITC Collections and Special Issues
SITC Immunotherapy Books
SITC's Guide to Managing Immunotherapy Toxicity Textbook
Cancer Immunotherapy Principles and Practice Textbook, 2nd Ed.
SITC Scientific Publications News
SITC Clinical Practice Guidelines
Clinical Practice Guidelines
Clinical Practice Guidelines Online Education
Clinical Practice Guidelines Mobile App
SITC Cancer Immunotherapy Guideline News
Patient Resource Guides
Policy & Advocacy
Advocacy
Crisis in Clinical Research
Global Immunotherapy Access
Government Relations
Quality and Value
Patient & Survivor Education & Resources
Membership
2023 SITC Election
Connect-a-Colleague
Volunteer
Path to SITC Leadership
Volunteer with SITC
Academy of Immuno-Oncology
About the Academy
Corporate Membership
Benefits, Categories & Application
Members Only
SITC Member Directory
Support SITC
The Forward Fund
Moving the Field Forward
Making a Difference
Named Funds and Awards
Early Career Scientist Awards
Richard V. Smalley Memorial Award and Lectureship
Steven A. Rosenberg Scholars Award
Technology Awards
Martin "Mac" Cheever Travel Award Fund
Sparkathon
The CheckPoints: SITC’s House Band
Ways to Make a Gift
Donate
Stocks and Securities
Estate and Planned Gifts
Corporate Support and Giving Opportunities
Corporate Giving Opportunities
Corporate Membership
Educational Grants
Sponsorship & Advertising
SITC Merchandise
Honor and Memorial Gifts
Make a Gift in Honor of a Loved One
Make a Gift in Memory of a Loved One
Our Donors and Supporters
2022 SITC Supporters
Forward
Fund Donors
About SITC
Awards and Recognition
Committees, Task Forces and Professional Interest Communities
Partnerships
SITC Policies
Board of Directors
SITC’s DEI Strategy
Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan
Virtual Roundtable on Diversity in Clinical Trial Enrollment
Media Room
SITC Press Releases
Scientific Meeting Highlights from SITC
Immune Monitor Archive
JITC Digest Archive
Cancer Immunotherapy Month
Career Connections
Mission & Vision
Contact SITC
The Connect Community
Create Account
My Profile
My Communities
My Libraries
The Sentinel - SITC Blog
SITC Cancer Immunotherapy Guideline News
Back to SITC Cancer Immunotherapy Guidelines
New SITC Gynecologic Cancer CPG Published in JITC
posted
06-09-2023
0
Recommend
On behalf of the Society for Immunotherapy of Cancer (SITC) and the SITC Gynecologic Cancer Immunotherapy Guideline Expert Panel, we are pleased to announce the publication of SITC’s Gynecologic Cancer Clinical Practice ...
0 comments
New SITC Gastrointestinal Cancer CPG Published in JITC
posted
06-07-2023
0
Recommend
SITC is pleased to announce the publication of our newest guideline, " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. " Clinicians ...
0 comments
Open Comment Period for SITC’s Melanoma Guideline Closes March 16
posted
02-23-2023
0
Recommend
The Society for Immunotherapy of Cancer (SITC) Melanoma Immunotherapy Guideline Expert Panel is pleased to invite public comment on the draft clinical practice guideline (CPG) “Society for Immunotherapy of Cancer (SITC) clinical ...
0 comments
Open Comment Periods for SITC’s Gynecologic Cancer and Gastrointestinal Cancer Guidelines Close January 27
posted
01-12-2023
0
Recommend
The Society for Immunotherapy of Cancer (SITC) is pleased to invite public comment on two new draft clinical practice guidelines (CPGs): “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy ...
0 comments
Help SITC Performance Test Our Next Quality Measure – Apply by January 5
posted
12-20-2022
0
Recommend
The Society for Immunotherapy of Cancer (SITC) is currently recruiting practices for clinician-level testing of the draft quality measure: Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint ...
0 comments
New Interactive Tools for SITC’s Nonmelanoma Skin Cancer and Lung Cancer & Mesothelioma Guidelines
posted
11-15-2022
0
Recommend
New interactive tools have been developed and integrated into the SITC CPG Mobile App for two of SITC’s guidelines that published in 2022. An overview of the guideline content as well as a highlight of the new tools and ...
0 comments
New Guideline Information and Tools Available – Lymphoma, RCC, ICI-rAEs, Urothelial Cancer & Prostate Cancer
posted
11-09-2022
0
Recommend
Previously published guidelines have new and updated content available only in the app. Below is an overview of the guidelines for which updates are available. A full description of the event that prompted the update as well ...
0 comments
New SITC Nonmelanoma Skin Cancer CPG Published in JITC
posted
07-28-2022
0
Recommend
SITC is pleased to announce the publication of our newest guideline, "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer." Clinicians will ...
0 comments
New SITC Lung Cancer and Mesothelioma CPG Published in JITC
posted
05-31-2022
0
Recommend
SITC is pleased to announce the publication of our newest guideline, " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma . " This ...
0 comments
SITC Cancer Immunotherapy Guidelines Mini Modules
posted
03-16-2022
0
Recommend
SITC is pleased to announce a new educational offering for the society’s clinical practice guidelines – SITC’s Cancer Immunotherapy Guidelines Mini Modules. Designed for practitioners with a desire to learn but with limited ...
0 comments
SITC Cancer Immunotherapy Guidelines Webinars
posted
03-11-2022
0
Recommend
SITC’s Cancer Immunotherapy Guidelines Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the clinical practice guidelines. On-demand ...
0 comments
SITC CPG Mobile App Update – Multiple Myeloma Guideline: D-Kd PLEIADES data and FDA approval
posted
02-01-2022
0
Recommend
The SITC Multiple Myeloma Expert Panel has updated the guidelines content and recommendations based on the November 30, 2021 FDA approval of daratumumab in combination with carfilzomib and dexamethasone (D-Kd) for adult patients ...
0 comments
SITC CPG Mobile App Update – Hepatocellular Carcinoma Guideline: New Treatment Algorithm
posted
01-01-2022
0
Recommend
The new hepatocellular carcinoma immunotherapy treatment algorithm was derived from the expert panel recommendations in the published SITC clinical practice guideline . This algorithm, available only in the free SITC ...
0 comments
SITC CPG Update – Breast Cancer Guideline: Withdrawn indication for atezolizumab
posted
12-03-2021
0
Recommend
On August 27, 2021, the indication for atezolizumab in combination with nab-paclitaxel as treatment for patients with triple-negative breast cancer (TNBC) whose tumors express PD-L1 was voluntarily withdrawn by the manufacturer. ...
0 comments
SITC Clinical Practice Guideline Mobile App Now Available
posted
09-14-2021
0
Recommend
The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, developed to provide clinicians with an on-the-go and easy-to-navigate reference with interactive ...
0 comments
SITC Clinical Practice Guideline on Immunotherapy for the Treatment of Hepatocellular Carcinoma Published in JITC
posted
09-12-2021
0
Recommend
The “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma ” was published in JITC September 12, 2021. SITC’s hepatocellular carcinoma ...
0 comments
SITC Clinical Practice Guideline on Immunotherapy for the Treatment of Breast Cancer Published in JITC
posted
08-13-2021
0
Recommend
The “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer ” was published in JITC August 13, 2021. SITC’s breast cancer expert panel developed this ...
0 comments
SITC Clinical Practice Guideline on Immunotherapy for the Treatment of Urothelial Cancer Published in JITC
posted
07-15-2021
0
Recommend
The “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer ” was published in JITC July 15, 2021 as an update to SITC’s 2017 guidelines on bladder ...
0 comments
SITC Clinical Practice Guideline on Immune Checkpoint Inhibitor-related Adverse Events Published in JITC
posted
06-25-2021
0
Recommend
The “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events ” was published in JITC June 25, 2021. While ICIs ...
0 comments
«
1
»
Membership Links
Join
Renew
Member Directory
My Profile
Get Involved
Email Sign-up
Volunteer
Support SITC
Contact Us
© 2022 Society for Immunotherapy of Cancer (SITC). All rights reserved.
Powered by Higher Logic